In February 2026, Zhuhai United Bio-Pharmaceutical Co., Ltd. reached an industry-university-research cooperation agreement with the Department of Pharmacy of Beijing Tsinghua Changgung Hospital. The two parties will leverage their respective top advantages in biomedical innovation and clinical medical research to develop high-efficiency moisturizing creams and other products targeting dry, damaged skin conditions caused by chronic, recurrent skin diseases such as atopic dermatitis, and proceed with translation and production.